XML 84 R74.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidating Financial Statements (Schedule of Condensed Consolidating Statements of Comprehensive Income) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 28, 2019
Mar. 29, 2019
Jun. 29, 2018
Mar. 30, 2018
Jun. 28, 2019
Jun. 29, 2018
Condensed Consolidating Financial Statements            
Net sales $ 823.3   $ 825.5   $ 1,613.9 $ 1,580.8
Cost of sales 434.4   431.5   889.9 839.3
Gross profit 388.9   394.0   724.0 741.5
Selling, general and administrative expenses 225.9   189.9   456.1 401.1
Research and development expenses 79.6   92.6   164.9 174.6
Restructuring charges, net (0.2)   58.8   4.0 87.0
Non-restructuring impairment charge 113.5   0.0   113.5 0.0
Operating (loss) income [1] (29.9)   52.7   (14.5) 78.8
Interest expense (71.5)   (95.1)   (154.2) (186.5)
Interest income 2.2   1.4   3.7 4.6
Other income (expense), net 74.4   (0.2)   90.7 4.4
Intercompany Interest And Fees 0.0   0.0   0.0 0.0
Income (Loss) from Equity Method Investments 0.0   0.0   0.0 0.0
Loss from continuing operations before income taxes (24.8)   (41.2)   (74.3) (98.7)
Income tax benefit (24.3)   (44.4)   (229.0) (81.0)
Income (Loss) from Continuing Operations (0.5)   3.2   154.7 (17.7)
(Loss) income from discontinued operations, net of income taxes 7.3   12.4   7.0 15.3
Net Income (Loss) 6.8 $ 154.9 15.6 $ (18.0) 161.7 (2.4)
Other Comprehensive Income (Loss), Net of Tax 2.4   (4.9)   3.7 (7.3)
Comprehensive Income (Loss) 9.2   10.7   165.4 (9.7)
Mallinckrodt plc            
Condensed Consolidating Financial Statements            
Net sales 0.0   0.0   0.0 0.0
Cost of sales 0.7   0.7   1.3 0.9
Gross profit (0.7)   (0.7)   (1.3) (0.9)
Selling, general and administrative expenses 13.9   11.3   25.2 17.7
Research and development expenses 1.8   1.7   3.2 2.2
Restructuring charges, net 0.0   0.0   0.0 0.0
Non-restructuring impairment charge 0.0       0.0  
Operating (loss) income (16.4)   (13.7)   (29.7) (20.8)
Interest expense (1.5)   (1.6)   (12.6) (4.6)
Interest income 2.8   2.2   15.0 4.4
Other income (expense), net 5.5   0.6   8.7 6.7
Intercompany Interest And Fees (3.5)   (4.0)   (10.0) (8.5)
Income (Loss) from Equity Method Investments 18.8   31.0   188.1 18.1
Loss from continuing operations before income taxes 5.7   14.5   159.5 (4.7)
Income tax benefit (1.1)   (1.1)   (2.2) (2.3)
Income (Loss) from Continuing Operations 6.8   15.6   161.7 (2.4)
(Loss) income from discontinued operations, net of income taxes 0.0   0.0   0.0 0.0
Net Income (Loss) 6.8   15.6   161.7 (2.4)
Other Comprehensive Income (Loss), Net of Tax 2.4   (4.9)   3.7 (7.3)
Comprehensive Income (Loss) 9.2   10.7   165.4 (9.7)
Mallinckrodt International Finance S.A.            
Condensed Consolidating Financial Statements            
Net sales 0.0   0.0   0.0 0.0
Cost of sales 0.0   0.0   0.0 0.0
Gross profit 0.0   0.0   0.0 0.0
Selling, general and administrative expenses 0.4   0.2   0.6 0.4
Research and development expenses 0.0   0.0   0.0 0.0
Restructuring charges, net 0.0   0.0   0.0 0.0
Non-restructuring impairment charge 0.0       0.0  
Operating (loss) income (0.4)   (0.2)   (0.6) (0.4)
Interest expense (61.8)   (110.0)   (132.1) (211.2)
Interest income 0.2   0.3   0.3 2.0
Other income (expense), net 29.5   0.0   30.7 2.8
Intercompany Interest And Fees 0.0   0.0   0.0 0.0
Income (Loss) from Equity Method Investments 69.7   232.9   368.1 408.3
Loss from continuing operations before income taxes 37.2   123.0   266.4 201.5
Income tax benefit 6.6   (1.2)   6.6 (2.0)
Income (Loss) from Continuing Operations 30.6   124.2   259.8 203.5
(Loss) income from discontinued operations, net of income taxes 2.9   0.1   2.7 0.0
Net Income (Loss) 33.5   124.3   262.5 203.5
Other Comprehensive Income (Loss), Net of Tax 2.4   (4.9)   3.7 (7.3)
Comprehensive Income (Loss) 35.9   119.4   266.2 196.2
Other Subsidiaries            
Condensed Consolidating Financial Statements            
Net sales 823.3   825.5   1,613.9 1,580.8
Cost of sales 433.7   430.8   888.6 838.4
Gross profit 389.6   394.7   725.3 742.4
Selling, general and administrative expenses 211.6   178.4   430.3 383.0
Research and development expenses 77.8   90.9   161.7 172.4
Restructuring charges, net (0.2)   58.8   4.0 87.0
Non-restructuring impairment charge 113.5       113.5  
Operating (loss) income (13.1)   66.6   15.8 100.0
Interest expense (97.4)   (7.7)   (136.4) (14.8)
Interest income 88.4   23.1   115.3 42.3
Other income (expense), net 39.4   (0.8)   51.3 (5.1)
Intercompany Interest And Fees 3.5   4.0   10.0 8.5
Income (Loss) from Equity Method Investments 33.5   124.3   262.5 203.5
Loss from continuing operations before income taxes 54.3   209.5   318.5 334.4
Income tax benefit (29.8)   (42.1)   (233.4) (76.7)
Income (Loss) from Continuing Operations 84.1   251.6   551.9 411.1
(Loss) income from discontinued operations, net of income taxes 4.4   12.3   4.3 15.3
Net Income (Loss) 88.5   263.9   556.2 426.4
Other Comprehensive Income (Loss), Net of Tax 4.3   (9.9)   6.7 (15.1)
Comprehensive Income (Loss) 92.8   254.0   562.9 411.3
Eliminations            
Condensed Consolidating Financial Statements            
Net sales 0.0   0.0   0.0 0.0
Cost of sales 0.0   0.0   0.0 0.0
Gross profit 0.0   0.0   0.0 0.0
Selling, general and administrative expenses 0.0   0.0   0.0 0.0
Research and development expenses 0.0   0.0   0.0 0.0
Restructuring charges, net 0.0   0.0   0.0 0.0
Non-restructuring impairment charge 0.0       0.0  
Operating (loss) income 0.0   0.0   0.0 0.0
Interest expense 89.2   24.2   126.9 44.1
Interest income (89.2)   (24.2)   (126.9) (44.1)
Other income (expense), net 0.0   0.0   0.0 0.0
Intercompany Interest And Fees 0.0   0.0   0.0 0.0
Income (Loss) from Equity Method Investments (122.0)   (388.2)   (818.7) (629.9)
Loss from continuing operations before income taxes (122.0)   (388.2)   (818.7) (629.9)
Income tax benefit 0.0   0.0   0.0 0.0
Income (Loss) from Continuing Operations (122.0)   (388.2)   (818.7) (629.9)
(Loss) income from discontinued operations, net of income taxes 0.0   0.0   0.0 0.0
Net Income (Loss) (122.0)   (388.2)   (818.7) (629.9)
Other Comprehensive Income (Loss), Net of Tax (6.7)   14.8   (10.4) 22.4
Comprehensive Income (Loss) $ (128.7)   $ (373.4)   $ (829.1) $ (607.5)
[1]
The amount of operating loss included in the Company's unaudited condensed consolidated statement of income for the three and six months ended June 29, 2018 related to the Sucampo Acquisition was $37.0 million and $67.7 million, respectively. Included within these results were $17.9 million and $27.0 million of amortization associated with intangibles recognized from this acquisition and $31.5 million and $46.5 million of expense associated with fair value adjustments of acquired inventory for the three and six months ended June 29, 2018, respectively.